Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study.
Yu Y, Ren W, He Z, Chen Y, Tan Y, Mao L, Ouyang W, Lu N, Ouyang J, Chen K, Li C, Zhang R, Wu Z, Su F, Wang Z, Hu Q, Xie C, Yao H. Yu Y, et al. Among authors: mao l. Breast Cancer Res. 2023 Nov 1;25(1):132. doi: 10.1186/s13058-023-01688-3. Breast Cancer Res. 2023. PMID: 37915093 Free PMC article.
Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y, He Z, Ouyang J, Tan Y, Chen Y, Gu Y, Mao L, Ren W, Wang J, Lin L, Wu Z, Liu J, Ou Q, Hu Q, Li A, Chen K, Li C, Lu N, Li X, Su F, Liu Q, Xie C, Yao H. Yu Y, et al. Among authors: mao l. EBioMedicine. 2021 Jul;69:103460. doi: 10.1016/j.ebiom.2021.103460. Epub 2021 Jul 4. EBioMedicine. 2021. PMID: 34233259 Free PMC article. Clinical Trial.
A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma.
Ouyang W, Jiang Y, Bu S, Tang T, Huang L, Chen M, Tan Y, Ou Q, Mao L, Mai Y, Yao H, Yu Y, Lin X. Ouyang W, et al. Among authors: mao l. Front Cell Dev Biol. 2022 Jan 24;9:758777. doi: 10.3389/fcell.2021.758777. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35141229 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35927597
Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19.
Jiang R, Han B, Xu W, Zhang X, Peng C, Dang Q, Sun W, Lin L, Lin Y, Fan L, Lv D, Shao L, Chen Y, Qiu Y, Han L, Kong W, Li G, Wang K, Peng J, Lin B, Tong Z, Lu X, Wang L, Gao F, Feng J, Li Y, Ma X, Wang J, Wang S, Shen W, Wang C, Yan K, Lin Z, Jin C, Mao L, Liu J, Kushnareva Y, Kotoi O, Zhu Z, Royal M, Brunswick M, Ji H, Xu X, Lu H. Jiang R, et al. Among authors: mao l. NEJM Evid. 2024 Jun;3(6):EVIDoa2400026. doi: 10.1056/EVIDoa2400026. Epub 2024 May 28. NEJM Evid. 2024. PMID: 38804790 Clinical Trial.
4,502 results